Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2025-12-05 00:00:00 ET · period of report 2024-12-13 · accession 0001568605-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-05 | 2025-06-04+ | SANA | Wyrick Susan D. | See Remarks | F - Tax | $3.38 | -5,132 | 167.8K | -3% | -$17.3K |
| DM | 2025-12-05 | 2025-06-03+ | SANA | Wyrick Susan D. | See Remarks | M - OptEx | $0.00 | +20.0K | 170.4K | +13% | $0 |
| DM | 2025-12-05 | 2024-12-13 | SANA | Wyrick Susan D. | See Remarks | A - Grant | $0.00 | +8,500 | 5,100 | New | $0 |
| DM | 2025-12-05 | 2025-06-03+ | SANA | Wyrick Susan D. | See Remarks | M - OptEx | $0.00 | -20.0K | 10.0K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | F | D | 2,565 | $4.44 | 178,263 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-03 | M | A | 10,000 | $0.00 | 180,828 | D | — | — | (F3) Includes 3,000 shares acquired on November 14, 2025 pursuant to the ESPP. |
| 3 | Common | Common Stock | 2025-06-04 | F | D | 2,567 | $2.32 | 167,828 | D | — | — | (F1) This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person. |
| 4 | Common | Common Stock | 2025-06-03 | M | A | 10,000 | $0.00 | 170,395 | D | — | — | (F1) This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person. (F2) Includes 3,000 shares acquired on May 15, 2025 pursuant to Sana Biotechnology, Inc.'s ("Sana") 2021 Employee Stock Purchase Plan (the "ESPP"). |
| 5 | Derivative | Restricted Stock Units | 2024-12-13 | A | A | 3,400 | $0.00 | 3,400 | D | — · — to — | 3,400 Common Stock | (F1) This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person. (F4) Each restricted stock unit represents a contingent right to receive one share of Sana common stock. (F5) The award vests as to 100% of the restricted stock units on December 13, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-12-13 | A | A | 5,100 | $0.00 | 5,100 | D | $1.89 · — to 2034-12-12 | 5,100 Common Stock | (F1) This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person. (F6) The option vests as to 100% of the shares underlying the option on January 13, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date. |
| 7 | Derivative | Restricted Stock Units | 2025-12-03 | M | D | 10,000 | $0.00 | 0 | D | — · — to — | 10,000 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Sana common stock. (F7) The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025. |
| 8 | Derivative | Restricted Stock Units | 2025-06-03 | M | D | 10,000 | $0.00 | 10,000 | D | — · — to — | 10,000 Common Stock | (F1) This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person. (F4) Each restricted stock unit represents a contingent right to receive one share of Sana common stock. (F7) The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025. |